Project Grant HT94252310719
Award Date
8/1/23
Completion Date
7/31/26
Dollars Obligated
$790K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92093, USA
Similar Awards
The University of California, San Diego (UCSD) has been awarded a $593,241 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund research to identify a new therapeutic target to prevent metastasis in pancreatic cancer. The three-year project, running from July 1, 2023 to June 30, 2026, leverages UCSD's expertise in cognitive science, computer science, and neuroscience to advance artificial intelligence...
The University of California, San Diego (UCSD) was awarded a $1,218,012 Project Grant from the Defense Health Agency on September 30, 2023 under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "GERMLINE INFLUENCE ON PROSTATE CANCER METASTASIS AND TREATMENT RESPONSE." The research aims to transform health care for Service Members and the American public by investigating medical solutions for the battlefield through innovative and impactful...
The University of California, San Diego (UCSD) was awarded a $592,500 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "MUTANT DNA-ACTIVATED KILLING SYSTEM FOR PRECISION BREAST CANCER THERAPY", will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research, to be conducted from February 1, 2025...
The University of California, San Diego (UCSD) was awarded a $1,184,999 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support UCSD's project "QUANTITATIVE ADVANCED DIFFUSION MRI FOR RELIABLE DETECTION AND ENHANCED TREATMENT OF HIGH-GRADE PROSTATE CANCER" from July 1, 2023 to June 30, 2027. Through this funding, UCSD will conduct research to advance the detection and treatment of high-grade prostate...
The University of California, San Diego (UCSD) was awarded a $551,207.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to research a new therapeutic target to prevent pancreatic cancer metastasis. The 3-year grant period runs from July 1, 2023 to June 30, 2026. The project aims to investigate medical solutions for the battlefield by transforming health care through innovative and impactful research in areas like cancer...
The University of California, San Diego (UCSD) was awarded a $790,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support UCSD research to mitigate traumatic brain injuries and neurological implications via the immunometabolite itaconate from June 1, 2023 through May 31, 2026. The Military Medical Research and Development program aims to transform military and public health care through...
The University of California, San Diego (UCSD) was awarded a $1,580,000 Project Grant from the Defense Health Agency's Military Medical Research and Development (CFDA 12.420) program. The grant, effective March 1, 2025 through February 29, 2028, will support "MULTIOMIC APPROACHES FOR NONINVASIVE PREDICTION OF INFLAMMATORY BOWEL DISEASE EXACERBATIONS." This research aims to transform healthcare for military service members, veterans, and the broader public through innovative...
This federal Project Grant award of $592,500.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research project titled "MUTANT DNA-ACTIVATED KILLING SYSTEM FOR PRECISION BREAST CANCER THERAPY" at the University of California, San Diego (UCSD). The project aims to develop innovative DNA-based therapies for precision treatment of breast cancer, with a performance period from February 1, 2025 to January 31,...
This $802,068 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by the University of California, San Diego (UCSD) to investigate how sublethal apoptotic signaling promotes melanoma adaptation to immune attack. The research aims to transform health care for service members and the broader public through innovative and impactful biomedical studies. The grant provides funding for UCSD's...
The University of California, San Diego (UCSD) was awarded a $1,126,780 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support UCSD research from July 1, 2023 through June 30, 2026 to study prostate cancer risk, detection, and outcomes in transgender and gender-nonconforming adults. Through this award, UCSD will apply its expertise in oncology, urology and LGBTQ+ health to further the Defense...